Pediatrics and Rare Diseases Group, Sanford Research, Sioux Falls, SD, USA.
Department of Biology, Augustana University, Sioux Falls, SD, USA.
Orphanet J Rare Dis. 2019 Jan 21;14(1):19. doi: 10.1186/s13023-019-0994-8.
CLN6-Batten disease is a rare neurodevelopmental disorder characterized pathologically by the accumulation of lysosomal storage material, glial activation and neurodegeneration, and phenotypically by loss of vision, motor coordination, and cognitive ability, with premature death occurring in the second decade of life. In this study, we investigate whether sex differences in a mouse model of CLN6-Batten disease impact disease onset and progression.
A number of noteworthy differences were observed including elevated accumulation of mitochondrial ATP synthase subunit C in the thalamus and cortex of female Cln6 mutant mice at 2 months of age. Moreover, female mutant mice showed more severe behavioral deficits. Beginning at 9 months of age, female mice demonstrated learning and memory deficits and suffered a more severe decline in motor coordination. Further, compared to their male counterparts, female animals succumbed to the disease at a slightly younger age, indicating an accelerated disease progression. Conversely, males showed a marked increase in microglial activation at 6 months of age in the cortex relative to females.
Thus, as female Cln6 mutant mice exhibit cellular and behavioral deficits that precede similar pathologies in male mutant mice, our findings suggest the need for consideration of sex-based differences in CLN6 disease progression during development of preclinical and clinical studies.
CLN6-Batten 病是一种罕见的神经发育障碍,其病理学特征为溶酶体贮积物的积累、神经胶质细胞激活和神经退行性变,表型特征为视力丧失、运动协调能力和认知能力丧失,患者在生命的第二个十年内死亡。在本研究中,我们研究了 CLN6-Batten 病小鼠模型中性别差异是否会影响疾病的发生和进展。
观察到了一些值得注意的差异,包括在 2 月龄的 CLN6 突变雌鼠的丘脑和皮质中堆积了更多的线粒体 ATP 合酶亚基 C。此外,雌性突变小鼠表现出更严重的行为缺陷。从 9 月龄开始,雌性小鼠表现出学习和记忆缺陷,运动协调能力严重下降。此外,与雄性相比,雌性动物在稍年轻的时候就屈服于疾病,表明疾病进展加速。相反,雄性动物在 6 月龄时大脑皮层的小胶质细胞激活明显增加。
因此,由于雌性 CLN6 突变小鼠表现出的细胞和行为缺陷先于雄性突变小鼠出现类似的病理学改变,我们的研究结果表明,在开发 CLN6 疾病的临床前和临床研究时,需要考虑性别差异对疾病进展的影响。